Regenxbio IncNASDAQ:RGNX
- LAST PRICE12.3200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots11.6500/ 1
- Ask / Lots12.7700/ 1
- Open / Previous Close0.0000 / 12.3200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RGNX |
|---|---|---|
| 09:32 ET | 14997 | 12.75 |
| 09:34 ET | 200 | 12.71 |
| 09:36 ET | 491 | 12.7 |
| 09:38 ET | 200 | 12.66 |
| 09:39 ET | 100 | 12.7 |
| 09:41 ET | 1000 | 12.7 |
| 09:43 ET | 200 | 12.6646 |
| 09:45 ET | 300 | 12.77 |
| 09:48 ET | 400 | 12.66 |
| 09:50 ET | 100 | 12.67 |
| 09:52 ET | 1200 | 12.66 |
| 09:54 ET | 100 | 12.68 |
| 09:56 ET | 700 | 12.6 |
| 09:57 ET | 200 | 12.57 |
| 10:01 ET | 200 | 12.58 |
| 10:03 ET | 300 | 12.54 |
| 10:06 ET | 600 | 12.58 |
| 10:08 ET | 800 | 12.615 |
| 10:12 ET | 200 | 12.615 |
| 10:14 ET | 400 | 12.6 |
| 10:15 ET | 600 | 12.59 |
| 10:17 ET | 400 | 12.57 |
| 10:19 ET | 200 | 12.56 |
| 10:21 ET | 200 | 12.57 |
| 10:24 ET | 926 | 12.55 |
| 10:26 ET | 100 | 12.54 |
| 10:28 ET | 500 | 12.55 |
| 10:30 ET | 400 | 12.54 |
| 10:32 ET | 13870 | 12.52 |
| 10:33 ET | 880 | 12.52 |
| 10:35 ET | 9188 | 12.53 |
| 10:37 ET | 858 | 12.56 |
| 10:39 ET | 100 | 12.56 |
| 10:42 ET | 1400 | 12.63 |
| 10:44 ET | 300 | 12.665 |
| 10:48 ET | 416 | 12.64 |
| 10:51 ET | 466 | 12.59 |
| 10:55 ET | 4155 | 12.62 |
| 11:00 ET | 5135 | 12.58 |
| 11:04 ET | 200 | 12.58 |
| 11:06 ET | 1400 | 12.57 |
| 11:08 ET | 200 | 12.5 |
| 11:09 ET | 1174 | 12.49 |
| 11:11 ET | 836 | 12.525 |
| 11:13 ET | 500 | 12.53 |
| 11:18 ET | 1553 | 12.52 |
| 11:20 ET | 400 | 12.53 |
| 11:22 ET | 550 | 12.495 |
| 11:24 ET | 100 | 12.52 |
| 11:26 ET | 800 | 12.52 |
| 11:27 ET | 100 | 12.53 |
| 11:29 ET | 725 | 12.54 |
| 11:31 ET | 800 | 12.5 |
| 11:33 ET | 517 | 12.5 |
| 11:36 ET | 1000 | 12.51 |
| 11:38 ET | 527 | 12.52 |
| 11:40 ET | 785 | 12.5 |
| 11:42 ET | 3800 | 12.51 |
| 11:44 ET | 300 | 12.5 |
| 11:45 ET | 700 | 12.52 |
| 11:47 ET | 600 | 12.49 |
| 11:51 ET | 1672 | 12.49 |
| 11:54 ET | 330 | 12.51 |
| 11:56 ET | 2965 | 12.51 |
| 11:58 ET | 2369 | 12.5 |
| 12:00 ET | 29250 | 12.5 |
| 12:02 ET | 3006 | 12.5 |
| 12:03 ET | 1600 | 12.53 |
| 12:07 ET | 694 | 12.509 |
| 12:09 ET | 700 | 12.515 |
| 12:12 ET | 1350 | 12.54 |
| 12:14 ET | 600 | 12.55 |
| 12:16 ET | 550 | 12.57 |
| 12:18 ET | 600 | 12.56 |
| 12:20 ET | 3044 | 12.58 |
| 12:21 ET | 1102 | 12.59 |
| 12:23 ET | 200 | 12.57 |
| 12:25 ET | 623 | 12.54 |
| 12:27 ET | 200 | 12.57 |
| 12:32 ET | 800 | 12.575 |
| 12:34 ET | 100 | 12.55 |
| 12:38 ET | 100 | 12.54 |
| 12:39 ET | 200 | 12.535 |
| 12:43 ET | 867 | 12.55 |
| 12:45 ET | 715 | 12.54 |
| 12:48 ET | 3351 | 12.53 |
| 12:50 ET | 4700 | 12.53 |
| 12:52 ET | 755 | 12.53 |
| 12:54 ET | 100 | 12.54 |
| 12:57 ET | 300 | 12.515 |
| 12:59 ET | 1300 | 12.525 |
| 01:03 ET | 200 | 12.52 |
| 01:06 ET | 1200 | 12.5 |
| 01:08 ET | 1525 | 12.5001 |
| 01:10 ET | 100 | 12.52 |
| 01:14 ET | 200 | 12.52 |
| 01:15 ET | 300 | 12.5 |
| 01:17 ET | 600 | 12.51 |
| 01:19 ET | 500 | 12.51 |
| 01:21 ET | 1925 | 12.5 |
| 01:24 ET | 400 | 12.54 |
| 01:26 ET | 100 | 12.53 |
| 01:28 ET | 100 | 12.535 |
| 01:32 ET | 300 | 12.53 |
| 01:33 ET | 200 | 12.53 |
| 01:35 ET | 955 | 12.55 |
| 01:37 ET | 100 | 12.545 |
| 01:39 ET | 700 | 12.55 |
| 01:42 ET | 600 | 12.505 |
| 01:46 ET | 1200 | 12.53 |
| 01:48 ET | 381 | 12.54 |
| 01:50 ET | 200 | 12.52 |
| 01:51 ET | 1100 | 12.505 |
| 01:53 ET | 1286 | 12.5 |
| 01:55 ET | 3972 | 12.5 |
| 01:57 ET | 381 | 12.5 |
| 02:00 ET | 1755 | 12.53 |
| 02:02 ET | 100 | 12.51 |
| 02:04 ET | 300 | 12.5 |
| 02:06 ET | 300 | 12.51 |
| 02:08 ET | 1740 | 12.51 |
| 02:11 ET | 129 | 12.5 |
| 02:13 ET | 1532 | 12.52 |
| 02:15 ET | 800 | 12.53 |
| 02:18 ET | 200 | 12.54 |
| 02:20 ET | 400 | 12.525 |
| 02:22 ET | 610 | 12.5201 |
| 02:24 ET | 700 | 12.5129 |
| 02:26 ET | 1200 | 12.5 |
| 02:27 ET | 978 | 12.5 |
| 02:29 ET | 300 | 12.5 |
| 02:31 ET | 1720 | 12.52 |
| 02:33 ET | 100 | 12.51 |
| 02:36 ET | 200 | 12.5 |
| 02:40 ET | 800 | 12.5 |
| 02:42 ET | 2759 | 12.51 |
| 02:44 ET | 1137 | 12.51 |
| 02:45 ET | 2100 | 12.5068 |
| 02:47 ET | 1760 | 12.5 |
| 02:49 ET | 8735 | 12.5 |
| 02:51 ET | 100 | 12.5 |
| 02:54 ET | 1155 | 12.5 |
| 02:56 ET | 2449 | 12.5 |
| 02:58 ET | 1584 | 12.52 |
| 03:00 ET | 113 | 12.5172 |
| 03:02 ET | 1600 | 12.5 |
| 03:03 ET | 900 | 12.4961 |
| 03:05 ET | 1200 | 12.5 |
| 03:07 ET | 500 | 12.5 |
| 03:09 ET | 16947 | 12.5 |
| 03:12 ET | 3190 | 12.5 |
| 03:14 ET | 2102 | 12.52 |
| 03:16 ET | 432 | 12.519 |
| 03:18 ET | 100 | 12.53 |
| 03:20 ET | 300 | 12.52 |
| 03:21 ET | 3566 | 12.53 |
| 03:23 ET | 100 | 12.53 |
| 03:25 ET | 2000 | 12.56 |
| 03:27 ET | 700 | 12.55 |
| 03:30 ET | 1249 | 12.56 |
| 03:32 ET | 2400 | 12.58 |
| 03:34 ET | 690 | 12.565 |
| 03:36 ET | 2321 | 12.57 |
| 03:38 ET | 500 | 12.54 |
| 03:39 ET | 948 | 12.52 |
| 03:41 ET | 550 | 12.51 |
| 03:43 ET | 2180 | 12.53 |
| 03:45 ET | 1400 | 12.52 |
| 03:48 ET | 2474 | 12.52 |
| 03:50 ET | 13772 | 12.5 |
| 03:52 ET | 5253 | 12.5 |
| 03:54 ET | 3436 | 12.515 |
| 03:56 ET | 11597 | 12.5 |
| 03:57 ET | 20335 | 12.35 |
| 03:59 ET | 78302 | 12.32 |
Jun 24, 2024
REGENXBIO Announces Expansion of AFFINITY DUCHENNE(R) Trial to Include a New Cohort of Younger Patients, from 7:05AM ET on Monday Jun 24, 2024 by Dow Jones
7:05AM ET on Monday Jun 24, 2024 by Dow Jones
Jun 20, 2024
DJ REGENXBIO Price Target Maintained With a $38.00/Share by HC Wainwright & Co., from 11:35AM ET on Thursday Jun 20, 2024 by Dow Jones
11:35AM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 18, 2024
Jun 12, 2024
DJ Regenxbio Shifts CEO to Chairman, COO to Chief Executive, from 7:26AM ET on Wednesday Jun 12, 2024 by Dow Jones
7:26AM ET on Wednesday Jun 12, 2024 by Dow JonesREGENXBIO Announces Leadership Transition, from 7:05AM ET on Wednesday Jun 12, 2024 by Dow Jones
7:05AM ET on Wednesday Jun 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Regenxbio Inc | 606.8M | -2.1x | --- |
SAGE Therapeutics Inc | 656.0M | -1.3x | --- |
Y-mAbs Therapeutics Inc | 537.1M | -24.7x | --- |
Zymeworks Inc | 591.1M | -4.7x | --- |
Urogen Pharma Ltd | 678.2M | -4.9x | --- |
WAVE Life Sciences Ltd | 584.1M | -9.3x | --- |
Company Information
REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three areas: retinal, neuromuscular and neurodegenerative diseases. Its investigational AAV therapeutics include ABBV-RGX-314, RGX-202 and RGX-121. It is developing ABBV-RGX-314 in collaboration with AbbVie to treat large patient populations impacted by wet age-related macular degeneration, diabetic retinopathy (DR) and other chronic retinal diseases characterized by loss of vision. It is developing RGX-202 to treat Duchenne muscular dystrophy (Duchenne). The Company is developing RGX-121 to treat Mucopolysaccharidosis type II (MPS II), a progressive, neurodegenerative lysosomal storage disorder.
Contact Information
- Headquarters
- 9804 Medical Center DriveROCKVILLE, MD, United States 20850
- Phone
- 240-552-8181
- Fax
- 302-655-5049
Executives
- Director
- Allan Fox
- Chairman of the Board
- Kenneth Mills
- Chief Financial Officer, Executive Vice President
- Vittal Vasista
- President, Chief Executive Officer, Director
- Curran Simpson
- Executive Vice President, Chief Scientific Officer
- Olivier Danos
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $606.8M |
|---|---|
Revenue (TTM) | $86.7M |
Shares Outstanding | 49.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $-5.88 |
Book Value | $7.08 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 7.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -306.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
